Synaptogenix Inc (SNPX)

[runncoach]

Placebos are real regardless of the treatment or illness. That's an established medical fact. Trials are set up to essentially rule out any placebo effect in efficacy of a drug or device within a particular probability metric. The fact that alzheimer's patients are already on other medications complicates things. Those that choose to run trials in other manners do not know what they have IMO. Luckily we did things the right way. The SA article might as well been titled "Results so incredible that there must be a catch". That's speaks volumes of our trial results IMO.

I'm sure the company is developing their strategy for this new money. Alkon stated in his interview late November that if they had the cash they would running 3 or 4 more trials. Well they have the cash now so I guess we should be patient. I still haven't seen the company sign on for the Noble conference that was so incredibly impressive last year with the panel presentation included. I had thought about trying to attend as Ft Lauderdale in the winter isn't a bad place to be. Apparently I won't be making that trip unfortunately, but you're right I think that when they start spreading the word soon that their will be an incredible amount of interest over the next few months.

You're certainly in my ball park of estimates on trial participants. I figure between the end of january and Valentine's day we'll have our last patient receive their first dose. We could already be there but certainly is coming soon. I encourage anyone out there to contact IR and make sure we get that PR. We got it with the last trial.